scholarly journals Regulation and biological function of a flagellar glucose transporter in Leishmania mexicana: a potential glucose sensor

2014 ◽  
Vol 29 (1) ◽  
pp. 11-24 ◽  
Author(s):  
Dayana Rodriguez‐Contreras ◽  
Hamide Aslan ◽  
Xiuhong Feng ◽  
Khoa Tran ◽  
Phillip A. Yates ◽  
...  
1996 ◽  
Vol 16 (11) ◽  
pp. 6419-6426 ◽  
Author(s):  
S Ozcan ◽  
T Leong ◽  
M Johnston

The RGT1 gene of Saccharomyces cerevisiae plays a central role in the glucose-induced expression of hexose transporter (HXT) genes. Genetic evidence suggests that it encodes a repressor of the HXT genes whose function is inhibited by glucose. Here, we report the isolation of RGT1 and demonstrate that it encodes a bifunctional transcription factor. Rgt1p displays three different transcriptional modes in response to glucose: (i) in the absence of glucose, it functions as a transcriptional repressor; (ii) high concentrations of glucose cause it to function as a transcriptional activator; and (iii) in cells growing on low levels of glucose, Rgt1p has a neutral role, neither repressing nor activating transcription. Glucose alters Rgt1p function through a pathway that includes two glucose sensors, Snf3p and Rgt2p, and Grr1p. The glucose transporter Snf3p, which appears to be a low-glucose sensor, is required for inhibition of Rgt1p repressor function by low levels of glucose. Rgt2p, a glucose transporter that functions as a high-glucose sensor, is required for conversion of Rgt1p into an activator by high levels of glucose. Grr1p, a component of the glucose signaling pathway, is required both for inactivation of Rgt1p repressor function by low levels of glucose and for conversion of Rgt1p into an activator at high levels of glucose. Thus, signals generated by two different glucose sensors act through Grr1p to determine Rgt1p function.


2016 ◽  
pp. AAC.00218-16 ◽  
Author(s):  
Thomas E. Kraft ◽  
Monique R. Heitmeier ◽  
Marina Putanko ◽  
Rachel L. Edwards ◽  
Ma. Xenia G. Ilagan ◽  
...  

The glucose transporter PfHT is essential to the survival of the malaria parasitePlasmodium falciparumand has been shown to be a druggable target with high potential for pharmacological intervention. Identification of compounds against novel drug targets is crucial to combating resistance against current therapeutics. Here, we describe the development of a cell-based assay system readily adaptable to high-throughput screening that directly measures compound effects on PfHT-mediated glucose transport. Intracellular glucose concentrations are detected using a genetically encoded fluorescence resonance energy transfer (FRET)-based glucose-sensor. This allows assessment of the ability of small molecules to inhibit glucose uptake with high accuracy (Z'-factor of >0.8), thereby eliminating the need for radiolabeled substrates. Furthermore, we have adapted this assay to counter screen PfHT hits against the human orthologues GLUT1, 2, 3 and 4. We report the identification of several hits after screening the Medicines for Malaria Venture (MMV) Malaria Box, a library of 400 compounds known to inhibit erythrocytic development ofP. falciparum. Hit compounds were characterized by determining the half-maximal inhibitory concentration (IC50) for the uptake of radiolabeled glucose into isolatedP. falciparumparasites. One of our hits, compound MMV009085, shows high potency and ortholog selectivity, thereby successfully validating our assay for anti-malarial screening.


2020 ◽  
Author(s):  
Felice D. Kelly ◽  
Khoa D. Tran ◽  
Jess Hatfield ◽  
Kat Schmidt ◽  
Marco A. Sanchez ◽  
...  

AbstractPrevious studies in Leishmania mexicana have identified the cytoskeletal protein KHARON as being important for both flagellar trafficking of the glucose transporter GT1 and for successful cytokinesis and survival of infectious amastigote forms inside mammalian macrophages. KHARON is located in three distinct regions of the cytoskeleton: the base of the flagellum, the subpellicular microtubules, and the mitotic spindle. To deconvolve the different functions for KHARON, we have identified two partner proteins, KHAP1 and KHAP2, that associate with KHARON. KHAP1 is located only in the subpellicular microtubules, while KHAP2 is located at the subpellicular microtubules and the base of the flagellum. Both the KHAP1 and KHAP2 null mutants are unable to execute cytokinesis but are able to traffic GT1 to the flagellum. These results confirm that KHARON assembles into distinct functional complexes and that the subpellicular complex is essential for cytokinesis and viability of disease-causing amastigotes but not for flagellar membrane trafficking.


2003 ◽  
Vol 100 (7) ◽  
pp. 3901-3906 ◽  
Author(s):  
R. J. S. Burchmore ◽  
D. Rodriguez-Contreras ◽  
K. McBride ◽  
M. P. Barrett ◽  
G. Modi ◽  
...  

2007 ◽  
Vol 153 (1) ◽  
pp. 9-18 ◽  
Author(s):  
Dayana Rodriguez-Contreras ◽  
Xiuhong Feng ◽  
Kristie M. Keeney ◽  
H.G. Archie Bouwer ◽  
Scott M. Landfear

2011 ◽  
Vol 175 (1) ◽  
pp. 39-48 ◽  
Author(s):  
Xiuhong Feng ◽  
Torben Feistel ◽  
Cosmo Buffalo ◽  
Ashley McCormack ◽  
Elizabeth Kruvand ◽  
...  

2008 ◽  
Vol 7 (8) ◽  
pp. 1299-1308 ◽  
Author(s):  
Martina Hnatova ◽  
Micheline Wésolowski-Louvel ◽  
Guenaëlle Dieppois ◽  
Julien Deffaud ◽  
Marc Lemaire

ABSTRACT The expression of the major glucose transporter gene, RAG1, is induced by glucose in Kluyveromyces lactis. This regulation involves several pathways, including one that is similar to Snf3/Rgt2-ScRgt1 in Saccharomyces cerevisiae. We have identified missing key components of the K. lactis glucose signaling pathway by comparison to the same pathway of S. cerevisiae. We characterized a new mutation, rag19, which impairs RAG1 regulation. The Rag19 protein is 43% identical to the F-box protein ScGrr1 of S. cerevisiae and is able to complement an Scgrr1 mutation. In the K. lactis genome, we identified a single gene, SMS1 (for similar to Mth1 and Std1), that encodes a protein showing an average of 50% identity with Mth1 and Std1, regulators of the ScRgt1 repressor. The suppression of the rag4 (glucose sensor), rag8 (casein kinase I), and rag19 mutations by the Δsms1 deletion, together with the restoration of RAG1 transcription in the double mutants, demonstrates that Sms1 is a negative regulator of RAG1 expression and is acting downstream of Rag4, Rag8, and Rag19 in the cascade. We report that Sms1 regulates KlRgt1 repressor activity by preventing its phosphorylation in the absence of glucose, and that SMS1 is regulated by glucose, both at the transcriptional and the posttranslational level. Two-hybrid interactions of Sms1 with the glucose sensor and KlRgt1 repressor suggest that Sms1 mediates the glucose signal from the plasma membrane to the nucleus. All of these data demonstrated that Sms1 was the K. lactis homolog of MTH1 and STD1 of S. cerevisiae. Interestingly, MTH1 and STD1 were unable to complement a Δsms1 mutation.


FEBS Letters ◽  
1987 ◽  
Vol 219 (2) ◽  
pp. 311-315 ◽  
Author(s):  
Stephen J.H. Ashcroft ◽  
Mark Stubbs

Sign in / Sign up

Export Citation Format

Share Document